Table 4 Baseline and final assessments according to outcome at the end of the observation period of the study (n = 572)
| Â | Outcome at the end of the observation period of the study | |
|---|---|---|
Discharged or still in care (n = 154) | Died (n = 417) | |
Sex, Female (%) | 51.9 | 44.1 |
Age Mean (Median, Range) | 75.1 (76.5,32 to 100) | 78 (80, 34 o 102) |
Baseline (T0) Mean ± SD (Median, Range) | ||
Breathlessness and Agitation | 2.5 ± 2.2 (2, 0 to 9) | 4.4 ± 2.9 (4, 0 to 12) |
Gastro-intestinal Issues | 0.2 ± 0.7 (0, 0 to 4) | 0.2 ± 0.8 (0, o to 12) |
Drowsiness and Delirium | 3.8 ± 2.4 (3, 0 to 12) | 4.7 ± 2.7 (4, 0 to 12) |
Flu-like symptoms | 2.6 ± 2.1 (2, 0 to 9) | 2.4 ± 2.4 (2, 0 to 12) |
Final (TF) (Mean, Median, Range) | ||
Breathlessness and Agitation | 1.6 ± 2.2 (1, 0 to 12) | 2.6 ± 2.5 (2. 0 to 12) |
Gastro-intestinal Issues | 0.2 ± 0.7 (0, 0 to 4) | 0 ± 0.1 (0, 0 to 2) |
Drowsiness and Delirium | 3.4 ± 2.6 (3, 0 to 10) | 5.2 ± 3.2 (6, 0 to 12) |
Flu-like symptoms | 1.3 ± 1.8 (0, 0 to 9) | 1 ± 1.7 (0, 0 to 10) |